NBIX Neurocrine Biosciences Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
01:26
Apr 07
Apr 07
Neurocrine's acquisition of Soleno adds a promising late-stage asset, providing strategic long-term growth for NBIX.
MED
About NBIX Analyst Coverage
Buzzberg tracks NBIX (Neurocrine Biosciences) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.